🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether IFX-1 is safe and effecti...
Status
Completed
Location
InflaRX Investigational Site
Start Date
2018-02-26
Trial ID
NCT03487276
The objective of this study was to determine the safety and therapeutic pot...
Status
Terminated
Location
Investigative Site
Start Date
2022-02-18
Trial ID
NCT05162066
Treatments Being Tested
The objectives of the study will be to investigate the safety and pharmacok...
Status
Completed
Location
Sumida Hospital, SOUSEIKAI Global Clinical Research Center
Start Date
2017-10-23
Trial ID
NCT05988008
The purpose of AROCFB-1001 is to evaluate the safety, tolerability, pharmac...
Status
Completed
Location
Research Site
Start Date
2024-04-05
Trial ID
NCT06209177
This will be an open-label, 2-part study. Part 1 will be a randomized, 2-se...
Status
Completed
Location
Clinical Trial Site
Start Date
2020-02-21
Trial ID
NCT04551599
Treatments Being Tested
The purpose of this study is to determine if the drug eculizumab reduces th...
Status
Completed
Location
Mayo Clinic
Start Date
2009-04
Trial ID
NCT00904826
Treatments Being Tested
This is a Phase 3b, open-label, single-arm, multicenter study to evaluate t...
Status
Completed
Location
Research Site
Start Date
2023-07-14
Trial ID
NCT05876351
Treatments Being Tested
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune conditi...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-08-01
Trial ID
NCT07010302
Treatments Being Tested
This is a Phase II, prospective, non-randomized, open-label trial involving...
Status
Withdrawn
Location
Princess Margaret Cancer Centre
Start Date
2021-01
Trial ID
NCT04262375
Treatments Being Tested
The complement system is an important component of the innate immune system...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-04-15
Trial ID
NCT06848296
Treatments Being Tested